Yitian Zhou

Karolinska Institutet

Research Interests

Explore related searches

Contact this professor

Google Scholar

Articles (20)

Collaborators (5)

Erik Eliasson

Karolinska Institutet

Stefania Koutsilieri

Karolinska Institutet

Souren Mkrtchian

Karolinska Institutet

Volker Lauschke

Assistant Professor

Karolinska Institutet

Gunnar Schulte

Karolinska Institutet

Yitian Zhou

Research Interests

Explore related searches

Contact this professor

Articles (20)

Collaborators (5)

Erik Eliasson

Stefania Koutsilieri

Souren Mkrtchian

Volker Lauschke

Gunnar Schulte

How do I reach out?

Meet Kite AI

Yitian Zhou

Research Interests

Explore related searches

Contact this professor

Articles (20)

Population-scale variability of the human UDP-glycosyltransferase gene family

APF2: an improved ensemble method for pharmacogenomic variant effect prediction

APF2: an improved ensemble method for pharmacogenomic variant effect prediction

Population-specific variations in KCNH2 predispose patients to delayed ventricular repolarization upon dihydroartemisinin-piperaquine therapy

Population-specific variations in <i>KCNH2</i> predispose patients to delayed ventricular repolarization upon dihydroartemisinin-piperaquine therapy

Next-generation sequencing in pharmacogenomics – fit for clinical decision support?

Meta-analysis of the global distribution of clinically relevant <i>CYP2C8</i> alleles and their inferred functional consequences

Pharmacogenomics Beyond Single Common Genetic Variants: The Way Forward

Challenges Related to the Use of Next-Generation Sequencing for the Optimization of Drug Therapy

Cross-Ancestry Genome-Wide Association Study Defines the Extended <i>CYP2D6</i> Locus as the Principal Genetic Determinant of Endoxifen Plasma Concentrations

A paradigm shift in pharmacogenomics: From candidate polymorphisms to comprehensive sequencing

The genetic landscape of major drug metabolizing cytochrome P450 genes—an updated analysis of population-scale sequencing data

Challenges and opportunities associated with rare-variant pharmacogenomics

Rare genetic variability in human drug target genes modulates drug response and can guide precision medicine

Cardiovascular Pharmacogenomics: An Update on Clinical Studies of Antithrombotic Drugs in Brazilian Patients

Computational Tools to Assess the Functional Consequences of Rare and Noncoding Pharmacogenetic Variability

Editorial: Population Pharmacogenomics (PGx): From Variant Identification to Clinical Implementation

Global Frequencies of Clinically Important HLA Alleles and Their Implications For the Cost-Effectiveness of Preemptive Pharmacogenetic Testing

Pharmacogene Sequencing of a Gabonese Population with Severe Plasmodium falciparum Malaria Reveals Multiple Novel Variants with Putative Relevance for Antimalarial Treatment

Pharmacogenomics in the era of next generation sequencing - from byte to bedside

Collaborators (5)

Erik Eliasson

Stefania Koutsilieri

Souren Mkrtchian

Volker Lauschke

Gunnar Schulte

How do I reach out?

Meet Kite AI